- Controversies
- Thomas A. Ban: Conflict of interest in neuropsychopharmacology.
- Thomas A. Ban: Development of our Vocabulary
- Thomas A. Ban: Education in Biological Psychiatry – Homage to Dr. Heinz E. Lehmann
- Pierre Baumann and Francois Ferrero: An official inqury of the clinical research activities (1946-1972) of Roland Kuhn (1912-2005).
- Barry Blackwell: Adumbration; A history lesson.
- Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry.
- Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry. Revised.
- Barry Blackwell: The anxiety enigma.
- Barry Blackwell: The Baby and The Bath Water.
- Barry Blackwell: The lithium controversy: A historical autopsy.
- John Court: A note on the history of Anorexia Nervosa
- Paul Devenyi: Addictions are not treatable diseases.
- Paul Devenyi: Pharmacotherapy of addictions
- Camille Drach Hojaij: Stein and Empathic Fulfilment.
- François Ferrero: Inquiry of the Geneva 1980s’ Psychiatry Crisis.
- Ernst J. Franzek: From the dichotomy to a three-part grouping of endogenous psychoses.
- Samuel Gershon: Device for naltrexone delivery
- Samuel Gershon: Ketamine, the “new” breakthrough in the treatment of depression.
- Samuel Gershon: Lithium history.
- Samuel Gershon: The trazodone cntrovery and its potential fatal consequences
- Ken Gillman: Medical science publishing: A slow-motion train wreck.
- David Healy: The shipwreck of the singular.
- Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany.
- Carlos R. Hojaij: A Psychopathological Marker For Biological Psychiatry: The Point of No Return and the “Something New" *
- Carlos R. Hojaij: “DSM-5: The Future of Psychiatric Diagnosis” or Continuing the Psychiatry DiSMantlement.
- Carlos R. Hojaij: Psychiatry and Medicine
- Carlos R. Hojaij: Towards a Psychiatric Biology
- David Janowsky: Cholinergic muscarinic mechanisms in depression and mania.
- Martin M. Katz: Component-Specific vs. Diagnosis-Specific Clinical Trial in Depression.
- Martin M. Katz: Multivantaged vs. conventional assessment method.
- Martin M. Katz: Onset of clinical action of antidepressants.
- Martin M. Katz: The need and rationale for shortenng the clinical trial for antidepressants
- Donald F. Klein, Max Fink, Edward Shorter and Thomas A. Ban: Comment exchange on Flagrant Catatonic Behavior..
- Joseph Knoll: Controversies on selegiline/(-)-deprenyl’s pharmacological spectrum after more than 50 years of its development
- Gin S. Malhi: A critical analysis of concepts in psychiatry
- Magda Malewska-Kasprzak, Agnieszka Permoda-Osip, Janusz Rybakowski:Disturbances of the purinergic system in affective disorders and schizophrenia.
- Antonio E. Nardi, Richard Balon, Guy Chouinard, Fiammetta Cosci, Steven Dubovsky, Giovanni A. Fava, Rafael C. Freire, David J. Greenblatt, John H. Krystal, Karl Rickels, Thomas Roth, Carl Salzman, Richard I. Shader, Edward K. Silberman, Nicoletta Sonino,.
- János Radó: Renal Toxicity of Lithium in Historical Perspective with Special Reference To Nephrogenic Diabetes Insipidus and its Treatment.
- Janos Radó: Desmopressin may counteract polyuria in lithium-induced nephrogenic diabetes insipidus. Review of the literature.
- Shridhar Sharma: Insulin coma treatment: Facts and controversies.
- Edward Shorter: The Q-T interval and the Mellaril story - a cautionary tale.
- Leonardo Tondo: Brief History of Suicide in Western Cultures.
- Hector Warnes: The gut-brain axis.